Navigation Links
Neuropathic Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Date:9/20/2011

) – Italy 29

3.12 Neuropathic Pain Therapeutics Market Forecast (2010–2018) – Italy 30

3.13 Neuropathic Pain Therapeutics Market Size (2005–2010) – Spain 31

3.14 Neuropathic Pain Therapeutics Market Forecast (2010–2018) – Spain 32

3.15 Neuropathic Pain Therapeutics Market Size (2005–2010) – Japan 33

3.16 Neuropathic Pain Therapeutics Market Size (2010–2018) – Japan 34

3.17 Drivers and Barriers for the Neuropathic Pain Therapeutics Market 35

3.17.1 Drivers for Neuropathic Pain Market 35

3.17.2 Barriers for Neuropathic Pain Market 35

3.18 Opportunity and Unmet Need Analysis 35

3.19 Key Takeaway 37

4 Neuropathic Pain Therapeutics - Competitive Assessment 38

4.1 Overview 38

4.2 Strategic Competitor Assessment 38

4.3 Product Profiles for the Major Marketed Products in the Neuropathic Pain Therapeutics Market 39

4.3.1 Lyrica (pregabalin) 39

4.3.2 Cymbalta (duloxetine) 40

4.3.3 Lidoderm (lidocaine patch 5%) 42

4.3.4 Neurontin (gabapentin) 43

4.3.5 Qutenza (capsaicin) 8% Patch 44

4.4 Key Takeaway 46

5 Global Neuropathic Pain Market - Pipeline Assessment 47

5.1 Overview 47

5.2 Strategic Pipeline Assessment 47

5.3 Neuropathic Pain Therapeutics Pipeline – Pipeline by Phases of Development 47

5.3.1 Neuropathic Pain Therapeutics – Regulatory Filed Products 48

5.3.2 Neuropathic Pain Therapeutics – Phase III Pipeline 48

5.3.3 Neuropathic Pain Therapeutics – Phase II Pipeline 49

5.3.4 Neuropathic Pain Therapeutics – Phase I Pipeline 50

5.3.5 Neuropathic Pain Market – Discovery and Pre-Clinical Pipeline 51

5.3.6 Technology Trends Analytic Framework 53

5.4 Neuropathic Pain Therapeutics Market – Pipeline by Mechanism of Action 55

5.5 Neuropathic Pain Therapeu
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Data Presented at AAN Show That Lacosamide Significantly Reduced Pain and was Generally Well Tolerated in Patients With Diabetic Neuropathic Pain
2. New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain
3. XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain
4. Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class
5. Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference
6. Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain
7. Although NeurogesX/Astellass Qutenza is Only Approved for Postherpetic Neuralgia, Surveyed U.S. Physicians are Likely to Prescribe It for All Neuropathic Pain Types
8. Pfizers Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In Japan
9. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
10. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 28, 2015 Voalte, the leader in ... in purpose-built wireless communications, today announced that Bay ... 104-bed acute-care facility in Webster, Texas ... One™ solution on Spectralink PIVOT™ purpose-built smartphones for ... Voalte a member of its AIMS Partner Program ...
(Date:7/28/2015)... July 21, 2015 Research and Markets ... the "Pharmaceutical Industry in China to 2020: ... Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, ... offering. This report tackles not ... China but also home grown companies ...
(Date:7/28/2015)... YORK , July 28, 2015 /PRNewswire/ ... a new research report with market overview, ... share, forecast, porter analysis, recent developments, competitive ... Global Industry Insight: Human Insulin Market ...      (Logo: http://photos.prnewswire.com/prnh/20150727/756778) Explore ...
Breaking Medicine Technology:Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 2Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 3Pharmaceutical Industry in China to 2020: Market to Increase Dramatically to $200 Billion 2Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 2Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 3Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 4Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 5
... -- China Medical Technologies, Inc. (the "Company") (Nasdaq: ... in-vitro diagnostic ("IVD") company, today announced that its ... ("GP Medical") and Beijing Yuande Bio-Medical Engineering Co., ... 415th, respectively, in the Deloitte Technology Fast 500 ...
... SUNNYVALE, Calif., Dec. 5, 2010 Pharmacyclics, Inc. (Nasdaq: ... Chronic Lymphocytic Leukemia (CLL) presentations at the American Society ... PCI-32765.  Two presentations report preclinical data, and one presentation ... patients with CLL or Small Lymphocytic Lymphoma (SLL) treated ...
Cached Medicine Technology:China Medical Technologies Announces its Subsidiaries, GP Medical and Beijing Yuande, Ranked 12th and 415th, respectively, in Deloitte Technology Fast 500 Asia Pacific 2010 Program 2Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765 2Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765 3Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765 4Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765 5Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765 6Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765 7
(Date:7/28/2015)... ... July 28, 2015 , ... World ... Out, a new household invention that makes shelling eggs an exact science. , ... says Scott Cooper, CEO and Creative Director of World Patent Marketing. “With a ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... the Lost and Found, a breakthrough technological invention. It is a wearable ... the consumer electronic industry reached a record high of $211.3 billion in 2014," ...
(Date:7/28/2015)... ... 2015 , ... The Denver Foundation and Blair-Caldwell African American ... a photographic and narrative exploration of African American giving, which runs August 1-31 ... Denver is one of only ten cities to host “The Soul of Philanthropy ...
(Date:7/28/2015)... NJ (PRWEB) , ... July 28, 2015 , ... Morristown ... in New Jersey, and one of the first five hospitals in the nation, to ... in three patients on July 23, and all are in good condition. , The ...
(Date:7/28/2015)... ... July 28, 2015 , ... Autism is ... 68 children currently affected with the disorder. For these families, identifying and paying ... recovery is extremely daunting. That’s where Talk About Curing Autism (TACA), a national ...
Breaking Medicine News(10 mins):Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 2Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 4Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 5Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 2Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 3Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 4Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 5Health News:"The Soul of Philanthropy Reframed and Exhibited” Comes to Denver 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:National TACA Autism Conference Offers Hope and Help to Families Affected by Autism 2
... routine scans for low-back pain unless they observe features ... Evidence-Based Practice Center at Oregon Health & Science University ... of the The Lancet . , The regular ... with low-back pain but no indication of a significant ...
... ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) a ... diabetic peripheral neuropathy and Molluscum Contagiosum today announced ... name to American Med Tech. (Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO ... the suspected naked short sellers and to get ...
... sober for the past 7 years , we are having an Anniversary Party ... lots of Food and fellowship,come join us in Celebration, call for information 1-888-80-SOBER. ... ... sober living houses in the country. The Only Men,s Sober living ...
... in Arizona and Hawaii; Expands California LocationsMISSION VIEJO, Calif., ... Code Pink Boot Camp, is pleased to announce that ... despite the turbulent economy and now includes additional locations ... Code Pink Boot Camp is thriving and growing in ...
... Cure Now," a nonprofit patient advocacy organization, has launched ... Americans interested in medical research be heard in the ... and special interests. The Web site allows people ... research a meaningful part of any stimulus bill that ...
... face little danger, Danish study says , , FRIDAY, Feb. ... do not have an increased risk of developing ovarian ... , There,s been ongoing debate about whether fertility ... have yielded conflicting findings, and concerns endure, especially for ...
Cached Medicine News:Health News:Routine scans for low-back pain do not improve outcomes 2Health News:Routine scans for low-back pain do not improve outcomes 3Health News:ReBuilder Medical Technologies, Inc. to Change Name to American Med Tech 2Health News:Cleveland House a Sober living Resort, is Celebrating 7 Year Anniversary 2Health News:Code Pink Boot Camp Thrives Despite Rough Economy 2Health News:Psoriasis Cure Now launches StimulateResearch.com to Ensure That Medical Research is Part of Stimulus Bill 2Health News:Fertility Drugs Do Not Increase Ovarian Cancer Risk 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: